Compare Toyota Motor Corp (TM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toyota Motor Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Toyota Motor Corp trades at $180.4 (market cap $212.22B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: Toyota Motor Corp pays a 3.51% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Toyota Motor Corp nearer its low. Which is the better fit depends on your goals.
| TM | XBI | |
|---|---|---|
Market Cap | $212.22B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $248.29 | $164.28 |
52-Week Low | $166.50 | $85.16 |
Enterprise Value | $376.42B | — |
Dividend Yield | 3.51% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
